7 Results for "

Dual-site inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Dual-site inhibitor" in MCE Product Catalog:

19
19 Cited Publications
Cat. No.: HY-101053
CAS No.: 179248-59-0
Purity:  99.93%
Synonyms: Src Kinase inhibitor 1; Src-l1
Target:  

Src

Research Areas:  

Cancer

Src Inhibitor 1 is a potent, ATP-competitive and selective dual site Src tyrosine kinase inhibitor with IC50 values of 44 nM for Src and 88nM for Lck.
loading...
    loading...
Cat. No.: HY-163944
CAS No.: 3081311-94-3
LL-K12-18 is a CDK12 kinase inhibitor and a dual-site molecular glue. LL-K12-18 inhibits human CDK12 with an IC50 value of 283.9 nM, and selectively degrades cyclin K via the ubiquitin-proteasome system by stabilizing the CDK12-DDB1 complex. LL-K12-18 downregulates DNA damage response genes, reduces the phosphorylation level of CTD Ser2 in RNA polymerase II, and modulates biomarkers such as ATM, RAD51, γ-H2AX and cleaved PARP, thereby effectively inducing apoptosis and inhibiting proliferation of breast cancer cells. LL-K12-18 exhibits high target selectivity and serves as a research tool for studies on triple-negative breast cancer .
loading...
    loading...
Cat. No.: HY-178031
Research Areas:  

Infection

HIV-1-IN-87 (Compound 11x) is a dual-site HIV-1 inhibitor targeting the non-nucleoside reverse transcriptase inhibitor binding pocket (NNIBP) and its adjacent site (NNIAS). HIV-1-IN-87 has potent antiviral activities against wild-type and mutant strains (such as L100I, K103N and Y181C) (EC50: 4.1-150 nM). HIV-1-IN-87 can be used for HIV-1 infections like acquired immune deficiency syndrome (AIDS) research .
loading...
    loading...
Cat. No.: HY-189013
CAS No.: 832082-44-7
Target:  

mAChR

Research Areas:  

Neurological Disease

THRX160209 is a dual-site antagonist of the M2 muscarinic acetylcholine receptor with M2 receptor subtype selectivity. THRX160209 binds simultaneously to the orthosteric site and a spatially distinct allosteric site, competitively inhibiting receptor activation at the acetylcholine binding pocket. THRX160209 exhibits affinity for all five muscarinic receptor subtypes. THRX160209 can be used in research related to neurological disorders .
loading...
    loading...
Cat. No.: HY-150108
CAS No.: 2250059-80-2
Target:  

mTOR Apoptosis Caspase

Research Areas:  

Cancer

RMC-4745 is a selective dual-site inhibitor of mTORC1, with a selectivity of 35 times for mTORC1 and mTORC2. RMC-4745 inhibits the proliferation of MCF-7 cells and upregulates Caspase-3/7 activity to induce cell apoptosis. RMC-4745 does not cause the upregulation of HER3 due to the inhibition of mTORC2. RMC-4745 can be used for the study of breast cancer .
loading...
    loading...
Cat. No.: HY-101053R
CAS No.: 179248-59-0
Synonyms: Src Kinase inhibitor 1 (Standard); Src-l1 (Standard)
Target:  

Src Reference Standards

Research Areas:  

Cancer

Src Inhibitor 1 (Standard) is the analytical standard of Src Inhibitor 1 (HY-101053). This product is intended for research and analytical applications. Src Inhibitor 1 is a potent, ATP-competitive and selective dual site Src tyrosine kinase inhibitor with IC50 values of 44 nM for Src and 88nM for Lck.
loading...
    loading...
Cat. No.: HY-122222
CAS No.: 393794-32-6
Target:  

PPAR

Research Areas:  

Others

MRL20 is a PPARγ constitutive and allosteric agonist. MRL20 enhances the interaction between PPARγ and the co-activating peptide of TRAP220, with its EC50 being 10 nM. Even after being covalently blocked in the constitutive pocket by GW9662 (HY-16578) or T0070907 (HY-13202), MRL20 can still strengthen the interaction between PPARγ and TRAP220, with EC50 values of 176 and 440 nM respectively. MRL20 fails to completely inhibit its cell activation effect. MRL20 can be used to study the allosteric regulatory mechanism of PPARγ .
loading...
    loading...